LIFEVANTAGE CORP Accrued Income Taxes, Current
LIFEVANTAGE CORP (LFVN) had Accrued Income Taxes, Current of $0 as of 2025-06-30, per its 10-K filed 2025-09-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2025-09-04
- 2025-06-30: Accrued Income Taxes, Current $0.00.
- 2024-06-30: Accrued Income Taxes, Current $202.00K.
- 2023-06-30: Accrued Income Taxes, Current $0.00.
- 2022-06-30: Accrued Income Taxes, Current $453.00K.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-04 | |
| 2024-06-30 | $202.00K 10-K · filed 2025-09-04 | |
| 2023-06-30 | $0.00 10-K · filed 2024-08-28 | |
| 2022-06-30 | $453.00K 10-K · filed 2023-08-28 | |
| 2021-06-30 | $830.00K 10-K · filed 2022-08-23 | |
| 2020-06-30 | $784.00K 10-K · filed 2021-08-19 | |
| 2019-06-30 | $592.00K 10-K · filed 2020-08-18 | |
| 2018-06-30 | $39.00K 10-K · filed 2019-08-14 | |
| 2017-06-30 | $215.00K 10-K · filed 2018-08-15 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $3.28M 10-K · filed 2017-09-07 | $1.21M 10-K · filed 2016-12-12 |
| 2015-06-30 | $0.00 10-K · filed 2016-12-12 | |
| 2011-12-31 | $136.31K 10-Q · filed 2012-02-14 | |
| 2011-06-30 | $36.00K 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |